VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.
Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders.
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Understanding the evolving phenotype of vascular complications in telomere biology disorders.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita. Blood. 2022 08 11; 140(6):608-618.
View in:
PubMed
subject areas
Dyskeratosis Congenita
Humans
Mutation
Telomerase
Telomere
Telomere Shortening
Telomere-Binding Proteins
authors with profiles
ALISON BERTUCH